Concepedia

IMpower130: Progression-free survival (PFS) and safety analysis from a randomised phase III study of carboplatin + nab-paclitaxel (CnP) with or without atezolizumab (atezo) as first-line (1L) therapy in advanced non-squamous NSCLC

Federico Cappuzzo, Michael McCleod, Maen Hussein, Alessandro Morabito, Achim Rittmeyer, Henry Jacob Conter, Hans‐Georg Kopp, Davey B. Daniel, Steve McCune, Tarek Mekhail,

Annals of Oncology · 2018 · 58 citations · 0 references

Open access

Concepts

MedicineOncologyPharmacologyCancer PharmacologyChemotherapyMedical OncologyChemotherapy Toxicity ManagementCombination ChemotherapyCytotoxic ChemotherapyLung Cancer PharmacotherapyOncology PharmacologyToxicity ManagementAtezolizumab TherapyProbabilistic Safety AnalysisSafety Analysis